Literature DB >> 33627520

Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome.

Hisaya Kato1,2, Yoshiro Maezawa1,2, Naoya Takayama3, Yasuo Ouchi3,4, Hiyori Kaneko1,2, Daisuke Kinoshita1,5, Aki Takada-Watanabe1, Motohiko Oshima6, Masaya Koshizaka1,2, Hideyuki Ogata7, Yoshitaka Kubota7, Nobuyuki Mitsukawa7, Koji Eto3,8, Atsushi Iwama6, Koutaro Yokote1,2.   

Abstract

Werner syndrome (WS), also known as adult progeria, is characterized by accelerated aging symptoms from a young age. Patients with WS experience painful intractable skin ulcers with calcifications in their extremities, subcutaneous lipoatrophy, and sarcopenia. However, there is no significant abnormality in the trunk skin, where the subcutaneous fat relatively accumulates. The cause of such differences between the limbs and trunk is unknown. To investigate the underlying mechanism behind these phenomena, we established and analyzed dermal fibroblasts from the foot and trunk of two WS patients. As a result, WS foot-derived fibroblasts showed decreased proliferative potential compared to that from the trunk, which correlated with the telomere shortening. Transcriptome analysis showed increased expression of genes involved in osteogenesis in the foot fibroblasts, while adipogenic and chondrogenic genes were downregulated in comparison with the trunk. Consistent with these findings, the adipogenic and chondrogenic differentiation capacity was significantly decreased in the foot fibroblasts in vitro. On the other hand, the osteogenic potential was mutually maintained and comparable in the foot and trunk fibroblasts. These distinct phenotypes in the foot and trunk fibroblasts are consistent with the clinical symptoms of WS and may partially explain the underlying mechanism of this disease phenotype.

Entities:  

Keywords:  Werner syndrome; adipogenesis; chondrogenesis; dermal fibroblasts; osteogenesis

Mesh:

Substances:

Year:  2021        PMID: 33627520      PMCID: PMC7950285          DOI: 10.18632/aging.202696

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  49 in total

1.  Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts.

Authors:  F S Wyllie; C J Jones; J W Skinner; M F Haughton; C Wallis; D Wynford-Thomas; R G Faragher; D Kipling
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome.

Authors:  S Mori; S Murano; K Yokote; M Takemoto; S Asaumi; A Take; Y Saito
Journal:  Int J Obes Relat Metab Disord       Date:  2001-02

3.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

4.  The Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription.

Authors:  Weiliang Tang; Ana I Robles; Richard P Beyer; Lucas T Gray; Giang H Nguyen; Junko Oshima; Nancy Maizels; Curtis C Harris; Raymond J Monnat
Journal:  Hum Mol Genet       Date:  2016-03-16       Impact factor: 6.150

Review 5.  A systems biology approach to anatomic diversity of skin.

Authors:  John L Rinn; Jordon K Wang; Helen Liu; Kelli Montgomery; Matt van de Rijn; Howard Y Chang
Journal:  J Invest Dermatol       Date:  2008-04       Impact factor: 8.551

Review 6.  The hallmarks of aging.

Authors:  Carlos López-Otín; Maria A Blasco; Linda Partridge; Manuel Serrano; Guido Kroemer
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

7.  Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential.

Authors:  Antonella Blasi; Carmela Martino; Luigi Balducci; Marilisa Saldarelli; Antonio Soleti; Stefania E Navone; Laura Canzi; Silvia Cristini; Gloria Invernici; Eugenio A Parati; Giulio Alessandri
Journal:  Vasc Cell       Date:  2011-02-08

8.  Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey.

Authors:  Minoru Takemoto; Seijiro Mori; Masafumi Kuzuya; Shinya Yoshimoto; Akira Shimamoto; Masahiko Igarashi; Yasuhito Tanaka; Tetsuro Miki; Koutaro Yokote
Journal:  Geriatr Gerontol Int       Date:  2012-07-23       Impact factor: 3.387

9.  Anatomic demarcation by positional variation in fibroblast gene expression programs.

Authors:  John L Rinn; Chanda Bondre; Hayes B Gladstone; Patrick O Brown; Howard Y Chang
Journal:  PLoS Genet       Date:  2006-07       Impact factor: 5.917

10.  Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration.

Authors:  Thomas H Ambrosi; Antonio Scialdone; Antonia Graja; Sabrina Gohlke; Anne-Marie Jank; Carla Bocian; Lena Woelk; Hua Fan; Darren W Logan; Annette Schürmann; Luis R Saraiva; Tim J Schulz
Journal:  Cell Stem Cell       Date:  2017-03-16       Impact factor: 24.633

View more
  3 in total

Review 1.  Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes.

Authors:  Hisaya Kato; Yoshiro Maezawa
Journal:  J Atheroscler Thromb       Date:  2021-09-11       Impact factor: 4.394

2.  Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome.

Authors:  Huifang Peng; Jie Wang; Yanyun Liu; Haiping Yang; Liping Li; Yujin Ma; Huiqin Zhuo; Hongwei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

3.  Calcification in Werner syndrome associated with lymphatic vessels aging.

Authors:  Hideyuki Ogata; Shinsuke Akita; Sanae Ikehara; Kazuhiko Azuma; Takashi Yamaguchi; Maihulan Maimaiti; Yoshiro Maezawa; Yoshitaka Kubota; Koutaro Yokote; Nobuyuki Mitsukawa; Yuzuru Ikehara
Journal:  Aging (Albany NY)       Date:  2021-12-27       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.